Researchers found that men who had three aspirin tablets a week cut down their risk of developing or dying from advanced prostate cancer.
According to American Cancer Society estimation, around 220,000 cases of prostate cancer were diagnosed in the US last year, making it the second most common cancer among men, after skin cancer. Around 27,500 men died of prostate cancer in 2015.
Cancer is slow-growing and does not spread beyond the prostate gland. In few cases, 99% of men are alive after five years and 98 % after 10 years.
The aspirin study is a analysis from the long-running physicians’ health study, a trial at Brigham and Women’s Hospital in Boston and the Harvard T.H. Chan School of Public Health. Earlier studies have yielded contradictory results on aspirin’s preventive benefits.